WWWei Wang

Wei Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei Wang has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • You-Sheng Liang

    Key Laboratory of National Health and Family Planning Commission on Parasitic Disease Control and Prevention, 117 Yangxiang, Meiyuan, Wuxi City, Jiangsu Province, 214064, China.

    6 shared publications
  • Jian-Rong Dai

    National Health Commission Key Laboratory of Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China

    3 shared publications
  • Fu-Liang Xu

    Affiliated Hospital of Weifang Medical University

    2 shared publications
  • Yuejin Liang

    Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA

    2 shared publications
  • Yun-Hai Wang

    Affiliated Hospital of Weifang Medical University

    2 shared publications
  • Feng Tang

    Jiangsu Provincial Key Laboratory of Molecular Biology of Parasites, 117 Yangxiang, Meiyuan, Wuxi City, Jiangsu Province 214064, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    The Global Economic Burden of Tuberculosis: Regional Disparities and Implications

    by Ji-Chun Wang, Qin-Yan Zuo, Jin-Xin Zheng, Wen-Wen Lv, Wei Wang, Shun-Xian Zhang

    Background: The global macroeconomic impact of Tuberculosis (TB) lacks comprehensive quantification using standardized economic frameworks. Methods: This analysis utilized data from the Global Burden of Disease (GBD) 2021 to assess the economic burden of TB through the lens of the Value of a Statistical Life Year (VSLY) framework, integrating willingness-to-pay-based economic measures. The study monetized the total disability-adjusted life years (DALYs) associated with TB to estimate overall welfare losses. Country-specific gross domestic product (GDP) data, adjusted for purchasing power parity (PPP), were sourced from the World Bank and integrated with DALY estimates to calculate the Value of Lost Welfare (VLW). Results: In 2021, the global economic cost of TB, expressed as VLW, was estimated at US$1.98 trillion (95% uncertainty interval [UI]: 1.62, 2.45), representing 1.29% (95% UI: 1.05, 1.60) of global GDP. The economic impact of TB was disproportionately distributed across regions, with countries of low Socio-Demographic Index (SDI) facing the most severe burden, where VLW represented 7.83% (95% UI: 5.70, 11.20) of GDP. Lower-middle SDI regions experienced a VLW impact of 5.28% (95% UI: 4.30, 6.58). Sub-Saharan Africa (US$406.2 billion; 8.40% of GDP) and South Asia (US$822.5 billion; 5.70% of GDP) were identified as the most economically affected super-regions. India bore the highest absolute economic burden (US$477.5 billion). In contrast, high-SDI countries demonstrated a VLW-to-GDP ratio of just 0.10% (95% UI: 0.09, 0.12). Conclusions: Prioritizing TB control in economic policy is urgently needed. Equitable resource allocation to high-burden regions is vital to alleviate the disease's economic consequences and improve global health.


  • Open Access

    Editorial: Immunological aspects of emerging and re-emerging zoonoses

    by Wei Wang, Jingxin Li, Yuejin Liang, Wenping Gong

    Immunological aspects of emerging and re-emerging zoonoses Zoonoses, a group of diseases that are transmitted between animals and humans, are considered as the most prevalent infections in humans (1). They present substantial global health threats and continue to pose significant challenges to both the scientific community and public health systems (2). Currently, approximately 60% of identified infectious diseases and 75% of emerging infectious diseases originate from zoonotic sources (3). Globally, zoonoses are estimated to be responsible for 2.5 billion cases of human illness and 2.7 million human deaths annually, with an additional 5 to 6 million individuals at risk of contracting zoonotic infections (4). Emerging and re-emerging zoonoses are therefore considered as major and global challenges for public health in terms of their profound health impacts and economic burdens (5). Recently, the One Health approach has been widely recommended to address the challenges of zoonoses (6, 7). The current Research Topic consists of 9 publications including 6 original research articles and 3 review articles, covering immune responses, immunodiagnostics and immunotherapeutics of zoonoses, with the goal of improving the understanding of the immunological facets of emerging and re-emerging viral zoonoses in this changing world. This editorial aims to provide an overview of the contributing articles within this Research Topic and highlight their significance in advancing our understanding of zoonotic diseases. Coronaviruses are a large family of RNA viruses that may infect both humans and animals (8). Coronavirus disease 2019 (COVID-19), caused by the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (9), has been recognized as one of the deadliest infectious diseases in human history responsible for millions of human fatalities and trillions of economic losses (10, 11). A large number of studies have been therefore conducted with the aim to provide insights into the containment of the COVID-19 pandemic worldwide (12). In the current Research Topic, five articles focus on COVID-19. Jeon et al. found that increased interferon alpha 1 (IFNA1) and reduced interleukin (IL)-12p40 were closely linked to persistent hyperinflammation in COVID-19 pneumonia Frontiers in Immunology frontiersin.org 01


  • Open Access

    Editorial: Innovative tools to support the elimination of neglected tropical diseases (NTDs)

    by Wei Wang, Jian Li, Mohamed R. Habib

    Editorial: Innovative tools to support the elimination of neglected tropical diseases (NTDs)

  • Evaluating the risk of Schistosoma mansoni transmission in mainland China

    by Guoli Qu, Wei Wang, Xiaomin Lu, Jianrong Dai, Xiaoheng Li, Yousheng Liang

    Biomphalaria straminea, an intermediate host of Schistosoma mansoni, is predominantly distributed in the South Americas and Caribbean; however, this snail, as an invasive species, was introduced to Shenzhen, southern China, in 1981, and recent epidemiologic surveys demonstrate that the distribution of B. straminea has expanded across the Zhujiang River Basin, South China. In the presence of continuous importation of S. mansoni-infected cases, there is a growing concern about the transmission of S. mansoni in China. To evaluate the risk of S. mansoni transmission in China, we tested the compatibility of B. straminea captured from the snail habitats in southern China with S. mansoni in laboratory. We detected no S. mansoni infections in B. straminea following exposure to the parasite larvae at snail/miracidium ratios of 1:5, 1:10, 1:20, 1:40, and 1:80, while 6.7 to 66.7 % infections occurred in the control Biomphalaria glabrata depending on the ratio. The results of the present study demonstrate that the invasive B. straminea snails seem to be incompatible with S. mansoni, suggesting a low risk of S. mansoni transmission in mainland China.


  • Open Access

    Stem cell therapy: a novel treatment option for cerebral malaria?

    by Wei Wang, Hui Qian, Jun Cao

    Cerebral malaria, a severe form of the disease, is one of the most severe complications of infection with Plasmodium parasites and a leading cause of malaria mortality. Currently available antimalarial therapy has proven insufficient to prevent neurological complications and death in all cases of cerebral malaria. Souza and colleagues observed that transplantation of bone marrow-derived mesenchymal stromal cells (BM-MSCs) increased survival, reduced parasitemia, decreased malaria pigment accumulation in the spleen, liver and kidney, elevated Kupffer cell count in liver, alleviated renal injury and lung inflammation, and improved lung mechanics in an experimental mouse model of cerebral malaria. Although plenty of challenges lie ahead, their findings show the promise of BM-MSC therapy for the treatment of cerebral malaria.


  • Global extent of chloroquine-resistant Plasmodium vivax

    by Wei Wang, Yuejin Liang, Zuliang Jie, Shouli Wu, Hui Wang


  • Open Access

    New Uses for Old Drugs: The Tale of Artemisinin Derivatives in the Elimination of Schistosomiasis Japonica in China

    by Yi-Xin Liu, Wei Wu, Yue-Jin Liang, Zu-Liang Jie, Hui Wang, Wei Wang, Yi-Xin Huang

    Artemisinin (qinghaosu), extracted from the Chinese herb Artemisia annua L. in 1972, and its three major derivatives—artemether, artesunate and dihydroartemisinin—were firstly identified as antimalarials and found active against all species of the malaria parasite. Since the early 1980s, artemisinin and its derivatives have been found efficacious against Schistosoma spp., notably larval parasites, and artemisinin derivatives have played a critical role in the prevention and treatment of human schistosomiasis in China. Currently, China is moving towards the progress of schistosomiasis elimination. However, the potential development of praziquantel resistance may pose a great threat to the progress of elimination of schistosomiasis japonica in China. Fortunately, these three major artemisinin derivatives also exhibit actions against adult parasites, and reduced sensitivity to artemether, artesunate and dihydroartemisinin has been detected in praziquantel-resistant S. japonicum. In this review, we describe the application of artemisinin derivatives in the prevention and treatment of schistosomiasis japonica in China, so as to provide tools for the global agenda of schistosomiasis elimination. In addition to antimalarial and antischistosomal actions, they also show activities against other parasites and multiple cancers. Artemisinin derivatives, as old drugs identified firstly as antimalarials, continue to create new stories.


  • Open Access

    Apropos: factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China

    by Wei Wang, Jian-Rong Dai, You-Sheng Liang

    Currently, China is moving towards the elimination of schistosomiasis japonica. In a previous review, the factors affecting the progress towards the elimination of transmission of schistosomiasis in China have been summarized. Nevertheless, some factors were neglected. Hereby, we describe four other factors which may threaten the achievement of the goal of schistosomiasis elimination in China.


  • Resistance to niclosamide in Oncomelania hupensis, the intermediate host of Schistosoma japonicum: should we be worried?

    by Jian-Rong Dai, You-Zi Li, Wei Wang, Yun-Tian Xing, Guo-Li Qu, You-Sheng Liang

    SUMMARY: As the currently only available molluscicide, niclosamide has been widely used for snail control for over 2 decades in China. There is therefore a concern about the emergence of niclosamide-resistant snail populations following repeated, extensive use of the chemical. The purpose of this study was to investigate the likelihood of niclosamide resistance in Oncomelania hupensis in China. Active adult O. hupensis snails derived from 20 counties of 10 schistosomiasis-endemic provinces of China, of 10 snails in each drug concentration, were immersed in solutions of 1, 0·5, 0·25, 0·125, 0·063, 0·032, 0·016 and 0·008 mg L−1 of a 50% wettable powder of niclosamide ethanolamine salt (WPN) for 24 and 48 h at 25 °C, and the median lethal concentration (LC50) was estimated. Then, the 24- and 48-h WPN LC50 values were compared with those determined in the same sampling sites in 2002. The results indicated that the 24- and 48-h WPN LC50 values for O. hupensis were not significantly different from those determined in 2002 (P = 0·202 and 0·796, respectively). It is concluded that the current sensitivity of O. hupensis to niclosamide has not changed after more than 2 decades of repeated, extensive application in the main endemic foci of China, and there is no evidence of resistance to niclosamide detected in O. hupensis.